Plasmodium falciparum cellular proteins (Pf proteins)

Plasmodium falciparum cellular proteins represent the diverse array of proteins encoded by the P. falciparum genome, the primary causative agent of severe malaria in humans. These proteins are vital for the parasite's survival, reproduction, and evasion of the host immune system throughout its multi-stage life cycle (UniProt, 2023). Key functional groups include enzymes for DNA replication, metabolic pathways like the apicoplast-localized fatty acid synthesis, and specialized machinery for the invasion of human erythrocytes (PubMed, PMID: 30212463). Many of these proteins are the direct targets of current antimalarial drugs; for instance, dihydrofolate reductase is targeted by pyrimethamine, and the cytochrome bc1 complex is targeted by atovaquone (NIH, 2022). The study of these proteins is crucial for developing new therapeutics and vaccines, especially as the parasite develops resistance to existing treatments like artemisinin-based combination therapies (WHO, 2023). Understanding the structural and functional nuances of these cellular proteins remains a cornerstone of malariology and drug discovery efforts. Furthermore, proteins involved in heme detoxification, such as those in the digestive vacuole, are critical for parasite survival during the erythrocytic stage (PubChem, 2023). The identification of novel protein targets within this proteome is essential to overcome the growing threat of multi-drug resistant malaria strains.

Other names

Plasmodium falciparum proteomeMalaria parasite proteinsPf antigens

Inhibition of heme polymerization, inhibition of dihydrofolate reductase, inhibition of mitochondrial electron transport, induction of oxidative stress, and inhibition of protein synthesis.